Document is current
Any future updates will be listed below
-
Authors
Niihata, Kakuya https://orcid.org/0000-0001-9836-5750
Nishiwaki, Hiroki
Kinoshita, Maki
Kurosawa, Kentaro
Sakuramachi, Yui
Matsunaga, Satoshi
Okamura, Shintaro
Tsujii, Satoru
Hayashino, Yasuaki
Kurita, Noriaki
,
Ishii, Hitoshi
Kuwata, Hirohito
Fujimura, Maki
Takano, Kiyoko
Tsujii, Satoru
Okamura, Shintaro
Matsunaga, Satoshi
Hayashino, Yasuaki
Kitatani, Masako
Kitatani, Mako
Matsunaga, Satoshi
Kondo, Yaeko
Fujita, Naotaka
Ueda, Rei
Kawata, Rie
Tanaka, Masami
Mashitani, Tsuyoshi
Furuya, Miyuki
Moritsuji, Yukari
Fujita, Yuki
Nakamura, Noriko
Sakamoto, Yoko
-
Funding
Funding for this research was provided by:
Manpei Suzuki Diabetes Foundation
Japan Society for the Promotion of Science (25460641/16K08897)
- License Information
-
More Information
Article History
Received: 23 February 2023
Accepted: 19 June 2023
First Online: 13 July 2023
Declarations
:
: Kakuya Niihata, Hiroki Nishiwaki, Maki Kinoshita, Kentaro Kurosawa, Yui Sakuramachi, Satoshi Matsunaga, Shintaro Okamura, Satoru Tsujii, and Yasuaki Hayashino declare that they have no conflicts of interest. Noriaki Kurita has served as a senior scientist at the Institute for Health Outcomes and Process Evaluation Research (iHope International, a non-profit organization), but was not compensated for his contribution to this study. Denka Seiken Co., Ltd., measured urinary C-megalin; however, the company had no role in designing the study; in collecting, analyzing, or interpretating the data; in writing the manuscript; and in the decision to submit the article for publication. Denka Seiken Co., Ltd., contracted this study to iHope International.
: This study conformed to the tenets of the Declaration of Helsinki and was approved by the institutional review boards of Tenri Hospital (approval no. 785) and Fukushima Medical University (approval no. 2966).
: All patients provided informed consent to participate in this study.
